{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:58:02Z","timestamp":1781690282071,"version":"3.54.5"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: HbA1c is widely used to identify adults at increased risk of type 2 diabetes mellitus (T2DM), but major guidance differs on whether the lower limit of an HbA1c-defined risk range should be 5.7% (39 mmol\/mol) or 6.0% (42 mmol\/mol). This systematic review evaluated the prognostic and screening utility of HbA1c 5.7\u20136.4% compared with HbA1c 6.0\u20136.4% and examined whether available evidence supports threshold-based allocation of preventive interventions. Methods: The review was reported in accordance with PRISMA 2020 and registered in PROSPERO (CRD42019134344). PubMed\/MEDLINE, Embase and the Cochrane Library were searched for studies published from 1 January 2016 to 1 January 2026. Eligible evidence comprised human studies in English, French, Hebrew, Italian or Spanish that evaluated HbA1c ranges below the diabetes diagnostic threshold in adults aged at least 40 years or younger adults with established risk factors. Two reviewers independently screened records and extracted data. Risk of bias was assessed using an adapted QUADAS-2 framework for threshold-performance evidence, supplemented by CASP-informed appraisal, and certainty was rated with GRADE domains. Narrative synthesis was selected because populations, thresholds, comparator tests, follow-up and outcome ascertainment were heterogeneous. Results: Seven studies were included. Evidence consistently supported a graded risk continuum rather than a single biological cut point. HbA1c 5.7\u20136.4% identifies more adults but includes many at low short-term absolute risk, whereas HbA1c 6.0\u20136.4%, especially 6.2\u20136.4% or combined HbA1c and fasting glucose abnormality, identifies fewer adults at higher near-term risk. Direct evidence comparing 5.7% versus 6.0% thresholds came mainly from one UK cohort, with supportive but indirect evidence from meta-analysis, routine-care cohorts and reversion studies. No trial randomized adults to intervention by HbA1c threshold, and eligible evidence did not directly address early diabetes-related morbidity by threshold. Conclusions: HbA1c below the diabetes diagnostic threshold should be interpreted as risk strata, not as a binary disease label. HbA1c 5.7\u20136.4% is defensible for broad, low-intensity preventive advice, while HbA1c 6.0\u20136.4% can be used to prioritize structured prevention and closer follow-up. The proposed tiered approach is a pragmatic, hypothesis-generating interpretation of the available evidence rather than a trial-validated intervention algorithm.<\/jats:p>","DOI":"10.3390\/jcm15124690","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:22:56Z","timestamp":1781684576000},"page":"4690","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycated Hemoglobin and Prediabetes: A Systematic Review of HbA1c Thresholds for Type 2 Diabetes Prevention"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4621-5404","authenticated-orcid":false,"given":"Dawid","family":"Karczewski","sequence":"first","affiliation":[{"name":"Cranston Ridge Medical Clinic, Calgary, AB T3M 3A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1991-9184","authenticated-orcid":false,"given":"Tomasz","family":"Karczewski","sequence":"additional","affiliation":[{"name":"Cranston Ridge Medical Clinic, Calgary, AB T3M 3A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Olsen","sequence":"additional","affiliation":[{"name":"Cranston Ridge Medical Clinic, Calgary, AB T3M 3A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2026). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care, 49, S27\u2013S49.","DOI":"10.2337\/dc26-S002"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcjd.2017.10.004","article-title":"Screening for Diabetes in Adults","volume":"42","author":"Ekoe","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"ref_4","unstructured":"National Institute for Health and Care Excellence (2012). Type 2 Diabetes: Prevention in People at High Risk, NICE. Public Health Guideline PH38."},{"key":"ref_5","unstructured":"World Health Organization (2011). Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus, WHO."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"International Expert Committee (2009). International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care, 32, 1327\u20131334.","DOI":"10.2337\/dc09-9033"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/dc07-1707","article-title":"Longitudinal Association of Glucose Metabolism with Retinopathy: Results from the Australian Diabetes Obesity and Lifestyle Study","volume":"31","author":"Tapp","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"i6538","DOI":"10.1136\/bmj.i6538","article-title":"Efficacy and Effectiveness of Screen and Treat Policies in Prevention of Type 2 Diabetes: Systematic Review and Meta-Analysis of Screening Tests and Interventions","volume":"356","author":"Barry","year":"2017","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"g4485","DOI":"10.1136\/bmj.g4485","article-title":"The Epidemic of Pre-Diabetes: The Medicine and the Politics","volume":"349","author":"Yudkin","year":"2014","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_11","first-page":"CD012661","article-title":"Development of Type 2 Diabetes Mellitus in People with Intermediate Hyperglycaemia","volume":"10","author":"Richter","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_14","unstructured":"Critical Appraisal Skills Programme (2018). CASP Cohort Study Checklist, CASP."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE Guidelines: 9. Rating Up the Quality of Evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e000794","DOI":"10.1136\/bmjdrc-2019-000794","article-title":"Comparing Different Definitions of Prediabetes with Subsequent Risk of Diabetes: An Individual Participant Data Meta-Analysis Involving 76,513 Individuals and 8208 Cases of Incident Diabetes","volume":"7","author":"Lee","year":"2019","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rodgers, L.R., Hill, A.V., Dennis, J.M., Craig, Z., May, B., Hattersley, A.T., McDonald, T.J., Andrews, R.C., Jones, A., and Shields, B.M. (2021). Choice of HbA1c Threshold for Identifying Individuals at High Risk of Type 2 Diabetes and Implications for Diabetes Prevention Programmes: A Cohort Study. BMC Med., 19.","DOI":"10.1186\/s12916-021-02054-w"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/02813432.2021.1958497","article-title":"Classifying and Communicating Risks in Prediabetes according to Fasting Glucose and\/or Glycated Hemoglobin: PREDAPS Cohort Study","volume":"39","author":"Regidor","year":"2021","journal-title":"Scand. J. Prim. Health Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1038\/s41598-021-87838-z","article-title":"The Heterogeneity of Reversion to Normoglycemia according to Prediabetes Type Is Not Explained by Lifestyle Factors","volume":"11","author":"Albaladejo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamainternmed.2020.8774","article-title":"Risk of Progression to Diabetes among Older Adults with Prediabetes","volume":"181","author":"Rooney","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110829","DOI":"10.1016\/j.diabres.2023.110829","article-title":"HbA1c-Defined Prediabetes and Progression to Type 2 Diabetes in Denmark: A Population-Based Study Based on Routine Clinical Care Laboratory Data","volume":"203","author":"Nicolaisen","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Meads, K., Machiraju, P., Shi, Y., and Colagiuri, S. (2026). Predicting Pre-Diabetes Progression: A Systematic Review and Meta-Analysis. BMJ Nutr. Prev. Health, e000877.","DOI":"10.1136\/bmjnph-2024-000877"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e001529","DOI":"10.1136\/bmjdrc-2020-001529","article-title":"Lifetime Risk to Progress from Prediabetes to Type 2 Diabetes among Women and Men: Comparison between American Diabetes Association and World Health Organization Diagnostic Criteria","volume":"8","author":"Ligthart","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1210\/jc.2017-00954","article-title":"HbA1c Identifies Subjects with Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction","volume":"102","author":"Mangiafico","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/dc09-1939","article-title":"A1C Level and Future Risk of Diabetes: A Systematic Review","volume":"33","author":"Zhang","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1111\/j.1464-5491.2012.03686.x","article-title":"Screening for Prediabetes to Predict Future Diabetes Using Various Cut-Off Points for HbA1c and Impaired Fasting Glucose: The Toranomon Hospital Health Management Center Study 4","volume":"29","author":"Heianza","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amepre.2010.09.022","article-title":"Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c: National Health and Nutrition Examination Survey 2005\u20132006","volume":"40","author":"Ackermann","year":"2011","journal-title":"Am. J. Prev. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of Regression from Prediabetes to Normal Glucose Regulation on Long-Term Reduction in Diabetes Risk: Results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jc.2011-1894","article-title":"Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glucose: Implications for the Diagnosis of Diabetes","volume":"97","author":"Herman","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-152-12-201006150-00004","article-title":"Glucose-Independent, Black-White Differences in Hemoglobin A1c Levels: A Cross-Sectional Analysis of 2 Studies","volume":"152","author":"Ziemer","year":"2010","journal-title":"Ann. Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4690\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:26:12Z","timestamp":1781688372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124690"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124690","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}